Ian M Bouligny

14PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRegenerative medicine (incl. stem cells)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

|Jan 26, 2026
Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.

Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla

|Sep 05, 2025
Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome.

Alexandre Bazinet, Guillermo Montalban-Bravo, Alex Bataller

|Aug 28, 2025
Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies.

Wei-Ying Jen, Sanam Loghavi, Alexandre Bazinet

|Aug 14, 2025
Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax.

Jennifer Croden, Wei-Ying Jen, Jennifer Marvin-Peek

|Jul 21, 2025
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy.

Alexandre Bazinet, Sanam Loghavi, Yue Wei

Pageof 3

Frequent Collaborators

9 joint publications

Tapan M Kadia

8 joint publications

Farhad Ravandi

8 joint publications

Naval G Daver

8 joint publications

Courtney DiNardo